Adicet Bio to Present at the Cantor Virtual Global Healthcare Conference
Adicet Bio (Nasdaq: ACET) announced that CEO Chen Schor will present at the Cantor Virtual Global Healthcare Conference on September 16, 2020, at 8:40 AM ET. A live audio webcast will be available on the company’s website, with a replay accessible for 30 days post-event.
The company specializes in developing allogeneic gamma delta T cell therapies for cancer and other diseases, enhancing immune responses with engineered T cells for better tumor targeting.
- None.
- None.
MENLO PARK, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that Chen Schor, President and Chief Executive Officer of Adicet Bio, will present at the Cantor Virtual Global Healthcare Conference on Wednesday, September 16, 2020 at 8:40 AM ET.
A live audio webcast of the presentation can be accessed on the Investors section of Adicet Bio’s website at https://investor.adicetbio.com. An archived replay will be available for 30 days following the presentation.
About Adicet Bio, Inc.
Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. For more information, please visit our website at http://www.adicetbio.com.
Adicet Bio., Inc.
Investor and Media Contacts:
Anne Bowdidge
abowdidge@adicetbio.com
Janhavi Mohite
Stern Investor Relations, Inc.
212-362-1200
janhavi.mohite@sternir.com
FAQ
What is Adicet Bio's stock symbol?
When will Chen Schor present at the Cantor Virtual Global Healthcare Conference?
Where can I listen to the Adicet Bio presentation?
What therapies does Adicet Bio develop?